scholarly journals P637 MMP-2 and -8 degraded and citrullinated-vimentin (VICM) correlates to disease activity in inflammatory bowel diseases

2019 ◽  
Vol 13 (Supplement_1) ◽  
pp. S436-S437
Author(s):  
L Godskesen ◽  
M Lindholm ◽  
J Høg Mortensen ◽  
A Krag ◽  
T Manon-Jensen ◽  
...  
2019 ◽  
Vol 156 (6) ◽  
pp. S-854
Author(s):  
Line E. Godskesen ◽  
Majken Lindholm ◽  
Joachim Høg Mortensen ◽  
Aleksander Krag ◽  
Tina Manon-Jensen ◽  
...  

2020 ◽  
Vol 27 (1) ◽  
pp. 10-11
Author(s):  
Yejoo Jeon ◽  
Berkeley N Limketkai

The Mediterranean diet was recently shown to benefit hepatic steatosis and disease activity in inflammatory bowel diseases. These findings advance our knowledge on dietary approaches for IBD and motivate inquiry on the role of obesity in IBD pathogenesis.


Author(s):  
Yonghong Yang ◽  
Cui Zhang ◽  
Dehuai Jing ◽  
Heng He ◽  
Xiaoyu Li ◽  
...  

Abstract Background Inflammatory bowel diseases (IBDs), including ulcerative colitis (UC) and Crohn’s disease (CD), are chronic inflammatory disorders. As is well known, interferon regulatory factor (IRF) 5 is closely associated with the pathogenesis of various inflammatory diseases. But the exact role of IRF5 in IBD remains unclear. Methods In this study, we detected IRF5 expression in peripheral blood mononuclear cells (PBMCs) and inflamed mucosa from IBD patients by immunohistochemistry, western blot, and quantitative real-time polymerase chain reaction. Peripheral blood CD4+ T cells were stimulated with inflammatory cytokines and transfected by lentivirus. Results In active IBD patients, the expression of IRF5 in PBMCs and inflamed colonic tissues was obviously increased and significantly associated with disease activity. Ectopic overexpression of IRF5 could promote the differentiation of IBD CD4+ T cells into Th1 and Th17 cells by regulating T-bet and RAR related orphan receptor C, whereas knockdown of IRF5 had the opposite effects. Tumor necrosis factor (TNF)-α upregulated expression of IRF5 in CD4+ T cells, but anti-TNF treatment with infliximab could markedly reduce IRF5 expression in CD4+ T cells and intestinal mucosa of CD patients. Conclusion Our study reveals a novel mechanism that IRF5 levels are correlated with disease activity in IBD and might function as a possible marker for the management of IBD via regulating Th1 and Th17 immune responses and cytokine production.


2016 ◽  
Vol 31 (6) ◽  
pp. 1120-1125 ◽  
Author(s):  
Mustafa Kaplan ◽  
Mahmut Yuksel ◽  
Ihsan Ates ◽  
Zeki Mesut Yalın Kilic ◽  
Hasan Kilic ◽  
...  

2019 ◽  
Vol 17 (1) ◽  
pp. 203-204
Author(s):  
Ashwin N. Ananthakrishnan ◽  
Christopher Martin ◽  
Sunanda Kane ◽  
Robert S. Sandler ◽  
Millie D. Long

Sign in / Sign up

Export Citation Format

Share Document